Zhejiang Xianju Pharmaceutical Co.,Ltd. (002332.SZ)
CNY 10.64
(0.09%)
CNY 10.64
(0.09%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.21 Billion CNY | 11.74% |
| 2022 | -1.37 Billion CNY | -160.75% |
| 2021 | -527.71 Million CNY | -103.5% |
| 2020 | -259.32 Million CNY | -134.87% |
| 2019 | 743.77 Million CNY | -15.43% |
| 2018 | 879.42 Million CNY | -12.75% |
| 2017 | 1 Billion CNY | 1809.55% |
| 2016 | 52.78 Million CNY | -58.28% |
| 2015 | 126.52 Million CNY | -78.82% |
| 2014 | 597.41 Million CNY | 8.13% |
| 2013 | 552.49 Million CNY | 96.97% |
| 2012 | 280.49 Million CNY | 433.9% |
| 2011 | 52.53 Million CNY | 122.74% |
| 2010 | -230.98 Million CNY | 13.46% |
| 2009 | -266.91 Million CNY | -165.0% |
| 2008 | 410.62 Million CNY | 34.72% |
| 2007 | 304.8 Million CNY | 13.15% |
| 2006 | 269.38 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -1.03 Billion CNY | 18.67% |
| 2024 Q1 | -1.27 Billion CNY | -4.66% |
| 2024 Q3 | -1.25 Billion CNY | -21.17% |
| 2023 Q2 | -1.29 Billion CNY | 8.86% |
| 2023 Q3 | -1.46 Billion CNY | -13.56% |
| 2023 Q4 | -1.21 Billion CNY | 17.37% |
| 2023 FY | -1.21 Billion CNY | 11.74% |
| 2023 Q1 | -1.42 Billion CNY | -3.2% |
| 2022 Q2 | -511.6 Million CNY | -10.17% |
| 2022 FY | -1.37 Billion CNY | -160.75% |
| 2022 Q4 | -1.37 Billion CNY | -75.88% |
| 2022 Q3 | -782.36 Million CNY | -52.92% |
| 2022 Q1 | -464.37 Million CNY | 12.0% |
| 2021 FY | -527.71 Million CNY | -103.5% |
| 2021 Q2 | -181.27 Million CNY | 29.06% |
| 2021 Q3 | -343.25 Million CNY | -89.35% |
| 2021 Q4 | -527.71 Million CNY | -53.74% |
| 2021 Q1 | -255.53 Million CNY | 1.46% |
| 2020 FY | -259.32 Million CNY | -134.87% |
| 2020 Q1 | 682.52 Million CNY | -8.24% |
| 2020 Q2 | 667.27 Million CNY | -2.23% |
| 2020 Q3 | 486.38 Million CNY | -27.11% |
| 2020 Q4 | -259.32 Million CNY | -153.32% |
| 2019 Q2 | 731.29 Million CNY | -8.83% |
| 2019 FY | 743.77 Million CNY | -15.43% |
| 2019 Q4 | 743.77 Million CNY | -10.74% |
| 2019 Q3 | 833.3 Million CNY | 13.95% |
| 2019 Q1 | 802.11 Million CNY | -8.79% |
| 2018 Q4 | 879.42 Million CNY | 5.87% |
| 2018 Q1 | 1.08 Billion CNY | 7.41% |
| 2018 FY | 879.42 Million CNY | -12.75% |
| 2018 Q2 | 928.99 Million CNY | -14.19% |
| 2018 Q3 | 830.69 Million CNY | -10.58% |
| 2017 FY | 1 Billion CNY | 1809.55% |
| 2017 Q4 | 1 Billion CNY | 321.11% |
| 2017 Q3 | 239.36 Million CNY | 332.22% |
| 2017 Q2 | 55.38 Million CNY | -67.46% |
| 2017 Q1 | 170.19 Million CNY | 222.43% |
| 2016 Q4 | 52.78 Million CNY | -72.54% |
| 2016 FY | 52.78 Million CNY | -58.28% |
| 2016 Q3 | 192.19 Million CNY | 36.85% |
| 2016 Q2 | 140.44 Million CNY | -31.54% |
| 2016 Q1 | 205.15 Million CNY | 62.15% |
| 2015 Q4 | 126.52 Million CNY | -82.71% |
| 2015 Q2 | 657.12 Million CNY | -6.25% |
| 2015 Q1 | 700.94 Million CNY | 17.33% |
| 2015 FY | 126.52 Million CNY | -78.82% |
| 2015 Q3 | 731.86 Million CNY | 11.37% |
| 2014 Q1 | 894.42 Million CNY | 61.89% |
| 2014 Q2 | 874.73 Million CNY | -2.2% |
| 2014 Q4 | 597.41 Million CNY | -18.08% |
| 2014 Q3 | 729.29 Million CNY | -16.63% |
| 2014 FY | 597.41 Million CNY | 8.13% |
| 2013 Q1 | 198.63 Million CNY | -29.18% |
| 2013 Q2 | 479.38 Million CNY | 141.34% |
| 2013 Q3 | 581.47 Million CNY | 21.3% |
| 2013 Q4 | 552.49 Million CNY | -4.98% |
| 2013 FY | 552.49 Million CNY | 96.97% |
| 2012 Q3 | 183.34 Million CNY | 85.06% |
| 2012 Q2 | 99.07 Million CNY | -41.77% |
| 2012 FY | 280.49 Million CNY | 433.9% |
| 2012 Q1 | 170.14 Million CNY | 223.86% |
| 2012 Q4 | 280.49 Million CNY | 52.99% |
| 2011 Q3 | 10.29 Million CNY | 118.59% |
| 2011 Q2 | -55.34 Million CNY | 70.51% |
| 2011 Q1 | -187.65 Million CNY | 18.76% |
| 2011 Q4 | 52.53 Million CNY | 410.52% |
| 2011 FY | 52.53 Million CNY | 122.74% |
| 2010 Q2 | -210.09 Million CNY | 12.48% |
| 2010 Q1 | -240.04 Million CNY | 10.07% |
| 2010 Q4 | -230.98 Million CNY | -24.63% |
| 2010 FY | -230.98 Million CNY | 13.46% |
| 2010 Q3 | -185.34 Million CNY | 11.78% |
| 2009 Q3 | 402.88 Million CNY | 1.03% |
| 2009 Q4 | -266.91 Million CNY | -166.25% |
| 2009 FY | -266.91 Million CNY | -165.0% |
| 2009 Q2 | 398.77 Million CNY | 0.0% |
| 2008 Q4 | 410.62 Million CNY | 0.0% |
| 2008 FY | 410.62 Million CNY | 34.72% |
| 2007 FY | 304.8 Million CNY | 13.15% |
| 2006 FY | 269.38 Million CNY | 0.0% |